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It is well recognized that oncologists should consider patients’ quality of life and functioning when planning and delivering
anticancer treatment, but a comprehensive assessment of how a patient feels requires a thorough inquiry. A standardized
measurement of patients’ quality of life may support clinicians in identifying important problems for discussion during the
limited time of the medical consultations. The aim of this study was to assess the feasibility of computer-administered
individual quality of life measurements in oncology clinics with immediate feedback of results to clinicians and to examine the
impact of the information on consultations. The study employed a prospective non-randomized design with pre-test post-test
within subjects comparisons and involved three medical oncologists and 28 cancer patients receiving chemotherapy. The
intervention consisted of completion of quality of life questionnaires before the consultations and informing clinicians of the
results. The main outcome measures were patients’ perceptions of the content of baseline and intervention consultations and
satisfaction with communication. A qualitative analysis of clinicians’ interviews was performed. When clinicians had the quality
of life results they enquired more often about daily activities (Z=72.71, P=0.007), emotional problems (Z=72.11, P=0.035)
and work related issues (Z=71.89, P=0.058). There was an increase in the number of issues discussed during the intervention
consultation (Z=71.89, P=0.059). Patients were highly satisﬁed with both consultations. The computer measurement was
well accepted by patients who felt that the questionnaires were a useful tool to tell the doctors about their problems. The
clinicians perceived that the quality of life data broadened the range of the clinical inquiry and helped them identify issues for
discussion. Having symptoms and functional problems expressed quantitatively on a scale was useful for detection of change
over time.
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Transfer of information between healthcare professionals and their
patients, in both directions will always remain a critically impor-
tant element in diagnosis, management and patient support. For
cancer patients the issues surrounding their quality of life (QL)
are recognized to be central to good patient care. Comprehensive
assessment of how a patient feels and functions requires a thorough
inquiry. The traditional medical history and physical examination
are often insufﬁcient for assessing the full range of health-related
problems in cancer patients and in chronically ill patients in gener-
al (Calkins et al, 1991; Passik et al, 1998). A standardized
measurement of patients’ symptoms and functioning offers an
alternative structured way of collecting subjective information.
Advances in health services research over the past decades have
provided tools to measure the effects of illness on the daily lives of
patients, in a standardized, reliable and valid way (Fitzpatrick et al,
1992; Ware, 1995). Multidimensional, self-reported questionnaires
(usually called quality of life or health status questionnaires) are
currently widely used in clinical research (Fayers et al, 1997). Several
studies have investigated the value of paper-based questionnaires in
clinical practice. These looked at patients with chronic diseases caus-
ing signiﬁcant functional impairment and suggested that the health
status reports provided accurate information, facilitated doctor-
patient communication, but in general did not have a detectable
impact on patients’ functional status (Kazis et al, 1990; Calkins et
al, 1994; Wagner et al, 1997). However, when resource and manage-
ment suggestions were incorporated into the physicians’ feedback,
there was an improvement in emotional well-being and social func-
tioning of the patients (Rubenstein et al, 1995). Two published
studies in oncology addressed the impact of individual QL assess-
ments on physicians’ behaviour and doctor-patient communication
(Detmar and Aaronson, 1998; Taenzer et al, 2000). The QL results
appeared to stimulate physicians to initiate discussions on speciﬁc
aspects of patients’ health and well-being.
The implementation of standardized QL measurement in clinical
practice is proving to be difﬁcult due to practical, methodological
and conceptual barriers (Deyo and Patrick, 1989; McHorney and
Tarlov, 1995). The logistical problem of gathering real-time ques-
tionnaire data for immediate use in medical practice can be
overcome by computer-based administration, scoring and presenta-
tion of QL results (Sigle and Porzsolt, 1996; Taenzer et al, 1997;
Velikova et al, 1999). However, most clinicians are not trained in
the evaluation of questionnaire data and may be uncertain how
to interpret and respond to the results. How to present to clini-
cians individual patient’s QL data in a way that helps them to
interpret and use it efﬁciently, remains an important area of
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feedback of QL data to clinicians: how clinicians incorporate the
information within the structure of the medical interview, does
the additional information change their behaviour, do they ﬁnd
it clinically useful, or do they ﬁnd any unfavourable effects. The
evaluation of any new clinical intervention should also include
an assessment of patients’ attitude and perceptions of the impact
on their care.
This project was therefore undertaken to assess the feasibility of
using computer-administered individual QL measurement in
oncology clinics with immediate feedback of results to clinicians
and to examine the impact of the QL information on the content
of the medical consultations and on patient satisfaction with
communication. We will also describe patients’ and physicians’
acceptance and attitude to the process.
METHODS
Study design
This was a prospective non-randomized study using pre-test post-
test within subjects comparisons. Cancer outpatients completed
two standard questionnaires on a touch-screen computer on two
occasions (baseline and intervention visits). Both times they were
reviewed by the same physician. Graphic and numeric summaries
of the results were given to the clinician only at the second inter-
vention visit. After the visits patients were asked about the content
of the consultations, their satisfaction with the visits and their atti-
tude to the use of QL data. Semi-structured interviews were
conducted with the clinicians after each intervention consultation
and at the end of the study.
Sample
Consecutive cancer patients receiving chemotherapy or biological
therapy at the Medical Oncology Outpatient Clinics at St James’s
University Hospital, Leeds between October 1998 and March
1999 were considered for participation. Patients were eligible for
the study if they were able to read and understand English, were
willing to give informed consent and were expected to attend the
clinic at least once after the baseline visit. Three clinicians (two
consultants and one specialist registrar) were selected at random
from all 10 medical oncologists at St James’s Hospital. We aimed
at a convenience sample of 10 patients per doctor which would
allow us to detect a moderate effect size (0.5) (Cohen, 1988) of
the intervention on patient satisfaction with 80% power and 5%
signiﬁcance level.
The project was approved by the Local Ethical Committee at St
James’s Hospital, Leeds. Written informed consent was obtained
from all participating patients and clinicians.
Intervention questionnaires
The European Organisation for Research and Treatment of Cancer
– Core Quality of Life Questionnaire version 3.0 (EORTC QLQ-
C30) and the Hospital Anxiety and Depression Scale (HADS) were
used. The EORTC QLQ-C30 is a 30 item cancer-speciﬁc question-
naire including functional scales (physical, emotional, cognitive,
social and role), a global health/QL scale, symptom scales (fatigue,
pain, nausea/vomiting), and six single items assessing symptoms
and ﬁnancial impact of disease (Aaronson et al, 1993). The raw
scores for the scales and items were linearly transformed to give
standard scores in the range 0–100. Higher scores on the function-
ing and global health scales indicate better functioning, higher
scores on the symptom scales represent a higher level of symptoms.
HADS is a 14-item instrument with two separate subscales for
anxiety and depression. Scores range from 0–21 on each scale with
higher scores indicating more distress. Scores above 11 suggest
probable cases of anxiety or depressive illness and scores between
8 and 10 – borderline cases (Zigmond and Snaith, 1983).
Both questionnaires were administered in electronic format
using computers with touch-screen monitors (the software was
developed by AB Smith and can be obtained by writing to the
author). The responses were scored immediately and the results
were printed in two different formats – numerical (only present
results) and graphical (incorporating present and previous results)
(Figure 1). The aim of having two different presentations of QL
results was to assess clinicians’ preferences.
Training clinicians in interpretation of QL results A 1-h
training session was conducted before the study was commenced.
The training session focused on the content of EORTC QLQ-C30
and HADS, the interpretation of the scores and the general popu-
lation reference data (Hjermstad et al, 1998; Fayers et al, 1998).
Examples of individual patients proﬁles were discussed in conjunc-
tion with their clinical data.
Outcome measures
Patients Patient perceptions of the content of the consultation
were assessed using a study speciﬁc checklist. It included seven
possible discussion topics: (1) overall condition: (2) usual daily
activities; (3) limitations in doing work or leisure activities; (4)
how they feel emotionally; (5) symptoms of illness; (6) side
effects of treatment; (7) impact of illness on relationships with
family and friends. These topics were derived from the content
of EORTC QLQ-C30. Patients were asked to indicate whether
or not the doctor discussed any of these topics during the
encounter.
Patient satisfaction with the clinic visit was assessed with a 17-
item Cancer Research Campaign Patient Satisfaction with
Communication Questionnaire (LJ Fallowﬁeld, personal commu-
nication). This instrument was initially based on the 51 item
Patient Satisfaction Questionnaire developed by Ware et al
(quoted in Wilkin et al, 1992). It was extensively adapted and
reﬁned for use in UK in two pilot studies involving 289 and
154 oncology patients. The resulting 17-item questionnaire was
psychometrically tested on a further sample of 629 cancer
patients. The instrument includes direct statements of opinion
about the consultation. Eight items are positively worded and nine
negatively worded. Each item is scored from 1 (strongly agree) to
5 (strongly disagree). A high score indicates a high level of satis-
faction. The range of scores is from 17 to 85. Principal
components factor analysis revealed three dimensions: (1) satisfac-
tion with rapport (six items – the doctor answered all questions,
seemed to know what she/he was doing, handled the consultation
well, did her/his best to keep me from worrying, seemed sympa-
thetic, told me what I wanted to know); (2) dissatisfaction with
doctor’s manner (six items – the doctor could be irritated, could
have been more respectful, too businesslike and impersonal,
lacked experience with my medical problems, made me feel
awkward, more attention to my privacy); (3) understanding (four
items – the doctor used medical terms, the doctor told me all
there was to know, satisﬁed with the medical care today, unclear
about some things the doctor told me).
At the end of the study patient attitude to the intervention was
assessed with a short questionnaire covering practical issues of
completing computer questionnaires in clinics, questionnaires’
content, patient beliefs whether their functioning should be consid-
ered by the doctors and the overall usefulness of the intervention
for their care (Appendix 1).
Clinicians The clinical usefulness of the QL information was
discussed with the physicians after each intervention consultation
using semi-structured interviews based on a questionnaire used
by Wagner et al (1997). The interviews covered the following
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Figure 1 Example of the graphic print-out of the quality of life results.
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questionnaires –whether the QL scores provided any new informa-
tion, information conﬁrming doctor’s knowledge, information
conﬂicting with the clinical assessment, accurate information and
clinically relevant of QL information; (2) usefulness of information
during the consultation – general question on usefulness and for
which part of the consultation, usefulness for communication
and usefulness for the management of the patient; (3) perceived
prolongation of the intervention consultations and by how many
minutes; and (4) preferences for format of presentation of QL data
(numerical or graphic). The questions on the quality of QL infor-
mation and clinical usefulness had a suggested 5-points response
format – not at all, a little, somewhat, quite a bit and very much,
but clinicians were encouraged to provide further comments.
An end-of-study meeting was conducted with the three doctors
together to discuss their experiences during the study. The follow-
ing topics were covered: opinion on QL information, clinical
usefulness, integration of QL data into the consultations, length
of consultations, presentation of QL results and training of clini-
cians. The discussion was taped and transcribed.
Statistical analysis
Wilcoxon signed rank test was used to compare: (1) the number of
baseline and intervention visits when each of the seven possible
discussion topics were included; (2) the overall number of topics
discussed during the baseline and the intervention consultations;
and (3) patient satisfaction with the baseline and the intervention
consultations. The data from doctors’ interviews and patients’ atti-
tude to QL questionnaires were analyzed descriptively. The end-of-
study group discussion with clinicians was subjected to qualitative
thematic analysis. The transcript was carefully reviewed indepen-
dently by two researchers (G Velikova and AB Smith) for key
phrases.Phrases wereorganizedinclusters, comparedwitheachother
and a set of core themes was derived (Miles and Huberman, 1994).
RESULTS
Patients’ characteristics
Forty-two patients were asked to take part in the study. Eight
patients (19%) refused to participate (two stated that they did
not like answering questions, one was taking part in a drug trial
involving completion of QL questionnaires and ﬁve did not give
a reason for refusal). Two patients completed the baseline assess-
ment but refused the 2nd assessment (one felt that the questions
were not relevant and the other was too ill to continue) and four
did not attend for another clinic appointment during the study
period due to changes in treatment plans. The analysis is based
on 28 patients completing both parts of the study, 22 females
and six males with median age 57.4 years (range 43–77 years).
Eighteen patients had ovarian cancer and 10 patients had malig-
nant melanoma. They were receiving either chemotherapy (24
patients) or biological therapy (four patients). Twenty-two patients
were married/cohabiting, four were divorced/widowed and two did
not endorse this item. Thirteen patients had basic school educa-
tion, nine studied in college, three had higher university
education and three missed this question. Fourteen patients were
retired, six continued to work full or part time, four were home-
makers, two checked other (education) and two responses were
missing. The age and gender of the refusing patients and of the
patients who did not complete the study was not signiﬁcantly
different from those of the participating patients (data not shown).
All patients completed the computer questionnaires during the
clinic waiting time, usually after they had routine blood samples
taken and were waiting to see the doctor. For the intervention visit
the print-out of the results was attached to the front of the medical
notes. Summary statistics of the EORTC QLQ-C30 and HADS
results are presented in Tables 1 and 2.
Patient perceptions of the content of the consultations
Table 3 presents patient opinion on what topics were discussed
during their consultations. Patients felt that if clinicians had the
QL results they enquired more often about usual daily activities
(23 of the intervention vs 13 of the baseline consultations,
Z=72.71, P=0.007) and emotional problems (24 of the interven-
tion vs 16 of the baseline consultations, Z=72.11, P=0.035).
Physicians also discussed more often limitations in doing work
or leisure activities (20 intervention vs 14 baseline consultations),
but the difference was of borderline signiﬁcance (Z=71.89,
P=0.058).
There was a small increase in the overall number of issues
discussed during the intervention consultation (Z=71.89,
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Table 1 EORTC QLQ-C30 results for baseline and intervention consultations
Baseline Baseline Baseline Intervention Intervention Intervention
EORTC QLQ-C30 mean, s.d. lower quartile upper quartile mean, s.d. lower quartile upper quartile
Function scales
a
Global QL 64.5 (19.3) 50.0 83.3 70.7 (18.7) 58.3 83.3
Physical function 69.9 (27.7) 46.7 93.3 70.0 (22.4) 53.3 86.7
Role function 60.5 (30.0) 50.0 83.3 70.4 (27.1) 50.0 100.0
Emotional function 70.1 (23.5) 58.3 91.7 73.8 (19.8) 66.7 91.7
Social function 73.5 (23.7) 66.7 100.0 77.8 (25.7) 66.7 100.0
Cognitive function 81.5 (21.3) 66.7 100.0 83.3 (20.1) 66.7 100.0
Symptom scales
b
Fatigue 33.3 (19.5) 22.2 44.4 36.2 (22.4) 22.2 55.6
Pain 17.3 (22.9) 0 33.3 15.4 (20.1) 0 33.3
Nausea/vomiting 19.1 (28.4) 0 33.3 14.2 (18.9) 0 16.7
Symptoms – single items
Appetite 16.1 (23.3) 0 33.3 12.4 (24.7) 0 33.3
Dyspnoea 17.3 (23.3) 0 33.3 20.9 (20.9) 0 33.3
Sleep 17.3 (19.3) 0 33.3 25.9 (28.2) 0 33.3
Constipation 17.3 (31.2) 0 33.3 8.6 (14.9) 0 33.3
Diarrhoea 8.6 (21.8) 0 0 8.6 (19.8) 0 0
Finance 4.9 (12.1) 0 0 4.9 (15.2) 0 0
aFunction scales – higher scores indicate better functioning;
bSymptoms scales and items – higher scores represent a higher level of symptoms.
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covered in baseline and intervention consultations. During the
intervention visit there was an increase of the consultations when
all seven topics were included and a decrease of the encounters
when only two topics were covered.
Patient satisfaction with communication
We observed high patient satisfaction with both consultations and
no difference between the two consultations (median and range for
baseline and intervention consultations were 82.5, 74–85 and 83.5,
70–85 respectively). The range of possible total scores on the
instrument is from 17 to 85. No difference was found either when
comparing the three different dimensions of satisfaction with
communication. The scores for baseline and intervention consulta-
tions on each of the three factors were respectively: Satisfaction
with rapport (possible range 6–30) – median 30, range 26–30
and median 30, range 18–30; Dissatisfaction with doctor’s manner
(possible range 6–30) – median 30, range 28–30 and median 30,
range 29–30; Understanding (possible range 4–20) – median 20,
range 16–20 and median 20, range 17–20.
Patient acceptance and attitude to QL intervention
Twenty-six patients completed the end-of-study questionnaires
(Appendix 1). Two patients did not return the questionnaires.
For presentation of results the response categories Deﬁnitely and
Probably Yes/No were combined. All patients who returned the
questionnaires were happy to do the computer questionnaires
and their visit was not prolonged or made more difﬁcult by the
study. Only one patient felt that the standard QL questionnaires
were not asking the right questions. The majority of the patients
felt that the doctors considered their usual daily activities
(n=23), how they feel emotionally (n=22) and their overall quality
of life (n=26) when advising them. They wanted the doctors to ask
them about their usual daily activities (n=20), feelings (n=23) and
overall quality of life (n=24). Twenty-three patients felt the touch-
screen questionnaires were useful to tell the doctor how they felt
physically and emotionally and 24 were willing to complete them
at each hospital visit as part of their usual care. Twenty-three
patients thought this personal information should be kept in their
medical notes, but only half (n=13) wanted to see the print-out of
their questionnaire results.
Clinical usefulness of the QL data from physician’s point of
view
Interviews after each intervention consultation (n=28) The
clinicians discussed the QL results in 25 and did not discuss them
in three consultations. On those three occasions the doctors either
knew the patient well or had seen him/her very recently. The quan-
titative results from the semi-structured interviews with the
physicians after each intervention consultation are presented in
Table 4. Although the doctors knew the majority of the study
patients well – 22 out of 28 (79%), the QL data still provided
new information in half of the cases. The information was accurate
and consistent with the medical assessment. There were four occa-
sions when the responses to some questions were somewhat
different from the clinical impression. In the ﬁrst case the physician
identiﬁed signiﬁcant insomnia and shortness of breath which were
not detected by the questionnaire. This patient needed a lot of help
while completing the questionnaire and obviously had problems
understanding some of the questions. The second case was a clini-
cally anxious patient who had ‘normal’ scores. In this case the
patient’s spouse had dictated the responses. In the other two cases
the QL results suggested symptoms (shortness of breath and pain)
which were not considered to be serious by the physician.
The doctors felt that the QL data enhanced communication with
the patients and contributed to some of the management decisions.
The changes suggested by QL data consisted of stopping
chemotherapy (n=1), readjusting symptomatic drugs (n=2), blood
transfusion (n=1), counselling about life style (n=3), reassurance
(n=1), discussion of depression (n=1).
The physicians felt that discussion of QL results may have
lengthened nine of all 28 consultations. They estimated the prolon-
gation to be between 1 and 5 min (median 3 min) and considered
this acceptable.
End of study discussion The qualitative content analysis of the
discussion with the three participating clinicians identiﬁed a
number of core themes. The doctors felt that the available informa-
tion broadened the range of the inquiry and also helped them to
focus their questions on relevant problems. Using the QL data in
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Table 2 HADS results for baseline and intervention consultations
Baseline Intervention
HADS (number of patients)
a (number of patients)
a
Anxiety sub-scale
571 8 2 1
8–10 7 3
411 2 4
Depression sub-scale
572 1 2 4
8–10 5 3
411 1 1
aOne case is missing (computer error).
Table 3 Patient perceptions about the topics discussed during the base-
line and intervention consultations (total number of consultations=28)
Baseline Intervention
consultations consultations
Discussion topic (number)
a (number)
a
Overall condition 27 27
Usual daily activities 13 23
b
Limitations in doing work or
leisure activities
14 20
How they feel emotionally 16 24
b
Symptoms of illness 24 24
Side effects of treatment 20 19
Impact of illness on relationships with
family and friends
10 13
aIndicates the number of consultations when the topic was discussed.
bP50.05
Wilcoxon signed rank test.
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Figure 2 Number of areas from the checklist discussed during baseline
and intervention consultations (based on 27 patients as one patient did not
return the post intervention questionnaire and was excluded from this
analysis).
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ã 2002 The Cancer Research Campaign British Journal of Cancer (2002) 86(1), 51–59the encounters helped in building rapport with the patients and
improved communication by giving patients chance to talk and
by adding to the probing about less physical aspects. Clinicians
were less clear how much the data inﬂuenced their decisions on
patient management. All doctors commented that there would be
times when the information may trigger a referral to other services
(psychologists, social workers).
The clinicians felt that having symptoms and functional
problems expressed quantitatively on a scale could be very useful
especially for detection of change over time. There was a strong
preference for the graphic format of presentation as it allowed to
see changes at a single glance.
The physicians expressed concerns that the use of this rather
broad, additional data may increase their workload.
DISCUSSION
Our study conﬁrms that computer-based individual QL assessment
in oncology clinics with immediate feedback of results to clinicians
is possible and feasible. The measurement procedure was integrated
into the usual clinic routine and all patients completed the task
within their waiting time.
We found that the QL data may have a positive effect on doctor-
patient interactions by highlighting additional areas for discussion
during the consultation. Even in these small numbers we showed a
signiﬁcant increase in the enquiries about daily activities and
emotional functioning. It is important to emphasize that this is an
increase from the patients’ point of view as we asked the patients
to report what issues were discussed with them. The design of the
study allowed us to show that patients can feel a signiﬁcant difference
in the content of their consultations if their doctors had structured
QL information. Taenzer et al (2000) published similar ﬁndings from
a randomized study of 53 lung cancer patients. In structured inter-
views after consultations, the patients reported that more issues
were addressed when the doctors had QL results. Using direct obser-
vation of oncology consultations Detmar and Aaronson (1998) found
that the QL information stimulated physicians to initiate discussions
on wider aspects of functioning, but there was no increase in the
patients’ rating of physicians’ awareness of their problems. Several
large studies in chronic diseases also suggested that feedback of health
status data may facilitate communication between patients and clin-
icians and enhance patients’ care (Kazis et al, 1990; Rubenstein et al,
1995; Wagner et al, 1997).
Our initial hypothesis was that if the QL results stimulate
doctors to discuss a broader range of issues during the consulta-
tion, this may result in higher patients satisfaction with doctor–
patient communication and overall satisfaction with the visit.
Therefore we attempted to measure this possible effect by a satis-
faction questionnaire. We were aware that patient satisfaction
with care questionnaires tended to yield highly positive responses
(Fitzpatrick, 1991; Hall and Dorman, 1988). Therefore, we carefully
chose a questionnaire which was speciﬁcally modiﬁed and tested in
cancer patients and which focused more narrowly on satisfaction
with communication during the last clinic visit. Unfortunately even
with this questionnaire, we observed that 25 out of 27 patients
(one missing questionnaire) had very high satisfaction scores,
above 79 (from a possible range 17–85), which represents a
signiﬁcant ‘ceiling’ effect. This makes the detection of improvement
difﬁcult. Taenzer et al (2000) reported very similar ﬁndings of high
satisfaction in their group of lung cancer patients. Indeed, it may
be that the concept of satisfaction is not an appropriate outcome
measure in patients with advanced cancer with relatively short
prognosis. People with serious diseases often give more favourable
evaluation of medical care (Ben-Sira, 1980). Our patients attended
a cancer centre with a concentration of experience and expertise in
their problems. The patients understood that the options for treat-
ment at this stage are limited and they were grateful for every help
and support that was offered. We feel that high satisfaction with
care among ill cancer patients is a psychological phenomenon that
can not be avoided and should be taken into account when plan-
ning future research into patient care.
The computer measurement was well accepted and the patients
who took part in the study felt that the questionnaires were a
useful tool to tell the doctors about their feelings and were happy
to complete them as part of their care. These positive results
should be interpreted with caution as they reﬂect the opinion only
of patients who completed the end of study questionnaire. We
approached 42 patients and eight of them refused to take part.
Two of those eight said that they did not like answering questions.
One patient refused the 2nd assessment because the questions were
not applicable to his situation. Two patients completed the 2nd
intervention questionnaires in clinic, but did not ﬁll in the end
of study questionnaire asking for their opinion about the proce-
dure. Therefore, we should assume that for those non-compliant
patients the procedure might have been burdensome and not
worthwhile. Overall, we feel that the proportion of patients who
refused to participate (eight patients initially and two patients later
i.e. 24%) and the proportion of patients completing both parts of
the study (28 out of 42 approached i.e. 67%) is similar to thera-
peutic studies using QL measures (Osoba, 1994). However, our
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Table 4 Clinicians’ evaluation of the usefulness of the QL data after each intervention consultation
QL data ‘quite a bit’ or QL data ‘not at all’ or ‘a
‘very’ informative or little’ informative or
useful useful
Number of Number of
Criterion consultations (%)
a consultations (%)
Information gained by QL data
Knowledge conﬁrmed 25 (89) 2 (7)
New information 16 (57) 12 (43)
Accurate information 24 (86) 0 (0)
Clinically relevant information 23 (82) 2 (7)
Clinical usefulness of the QL results
Overall clinical usefulness 24 (86) 4 (14)
contributing to overall patient assessment 16
contributing to the medical history taking 7
contributing to the building of doctor-patient relationship 4
Usefulness to communication 18 (64) 10 (35)
Usefulness to management 15 (54) 14 (46)
aThe percentages do not always add up to 100% as the middle response category ‘somewhat’ is not included in the table.
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always be a number of patients (approximately 20% of all clinic
attendants) for whom this approach of collecting QL information
may not be acceptable or suitable. These are likely to be people
who are physically very ill, emotionally distressed or simply not
interested. In addition, the clinicians chose not to use the QL
information in three out of 28 patients (10%), because they either
knew them very well or had seen them recently.
We believe that one of the major reasons for not applying QL
data in clinical practice is the lack of research data on its clinical
usefulness in individual patients and the lack of guidelines how
to integrate the data into the decision-making framework of a
medical consultation (Till et al, 1994). Therefore, in this research
project we placed an emphasis on detailed exploration of clini-
cians’ assessment of the value of QL information, how they
used the data during medical encounters and what were their
needs for effective use of the data. The three doctors who took
part in the study felt that the QL information was accurate,
consistent with their medical assessment and clinically relevant.
This practical observation is quite important and suggests that
health surveys can be used reliably in clinical practice to gather
information about individuals despite the methodological concern
that they may not be sufﬁciently precise (McHorney and Tarlov,
1995).
The main contribution of the QL data was in bringing addi-
tional information and broadening the range of inquiry. The
main impact on the consultation was in helping building rapport
and better communication with the patients. The QL results were
felt to be useful for exchanging information with other members
of the team and for referrals to other services. The opportunity
to have problems expressed on a scale and over time was rated
as particularly valuable.
The doctors expressed two major concerns. They were apprehen-
sive that the broad additional information may increase their
workload. They also recognized how difﬁcult it is to change their
set pattern of questioning and behaviour during a medical consul-
tation and include a new intervention. The doctors tended to
follow the usual structure of a medical encounter and included
the QL data towards the end to cover additional areas and give
the patients the opportunity to talk.
One of the limitations of this study is the lack of direct observa-
tion of the consultations. We felt that any method of observation
(i.e. tape or video recording or direct observation) may have an
impact on the consultations and patients’ and doctors’ responses
to the study questions. Therefore we decided to focus on patients’
and doctors’ perception and opinion about what happened during
the medical encounters. However we recognize that an in-depth
study of the effect of QL data on patient care would require formal
analysis of the content of the consultations and we are using this
approach in other studies.
Our results are encouraging but should be interpreted with
caution at this stage as they are based on a small sample of patients
and doctors. However they do suggest a potential for inﬂuencing
doctor-patient interactions when using computer-administered
standard QL questionnaires. It is unclear yet whether this broaden-
ing of the clinical enquiry will improve the process of care and
whether it will bring beneﬁts for the patients like better detection
of morbidity, better control of symptoms or better emotional
adjustment to cancer. Based on our results and on the ﬁndings
of other researchers, we believe that this approach deserves further
investigation and we are currently conducting a large randomized
prospective clinical trial assessing the impact of QL information
on the process and outcomes of medical care.
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Appendix 1–Quality of life measurement in daily oncology
practice
Patients’ Attitude Questionnaire
You may remember when we ﬁrst discussed with you the quality of life
study that it would be helpful to have feedback from those who partici-
pated. This information will give us clearer idea about how acceptable
and useful routine collection of quality of life data is to patients.
Please answer all of the questions by ticking the appropriate box. If you
have any other comments about this study please write them in the space
provided and the end of the questionnaire. Thank you for your help
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